27902765|t|Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.
27902765|a|Proper function of lysosomes is particularly important in neurons, as they cannot dilute accumulated toxic molecules and aggregates by cell division. Thus, impairment of lysosomal function plays an important role in neuronal degeneration and in the pathogenesis of numerous neurodegenerative diseases. In this work we analyzed how inhibition and/or loss of the major lysosomal proteases, the cysteine cathepsins B and L (CtsB/L), affects lysosomal function, cholesterol metabolism and degradation of the key Alzheimer's disease (AD) proteins. Here, we show that cysteine CtsB/L, and not the aspartyl cathepsin D (CtsD), represent a major lysosomal protease(s) that control lysosomal function, intracellular cholesterol trafficking and AD-like amyloidogenic features. Intriguingly, accumulation of free cholesterol in late endosomes/lysosomes upon CtsB/L inhibition resembled a phenotype characteristic for the rare neurodegenerative disorder Niemann-Pick type C (NPC). CtsB/L inhibition and not the inhibition of CtsD led to lysosomal impairment assessed by decreased degradation of EGF receptor, enhanced LysoTracker staining and accumulation of several lysosomal proteins LC3II, NPC1 and NPC2. By measuring the levels of NPC1 and ABCA1, the two major cholesterol efflux proteins, we showed that CtsB/L inhibition or genetic depletion caused accumulation of the NPC1 in lysosomes and downregulation of ABCA1 protein levels and its expression. Furthermore, we revealed that CtsB/L are involved in degradation of the key Alzheimer's proteins: amyloid-beta peptides (Abeta) and C-terminal fragments of the amyloid precursor protein (APP) and in degradation of beta-secretase (BACE1). Our results imply CtsB/L as major regulators of lysosomal function and demonstrate that CtsB/L may play an important role in intracellular cholesterol trafficking and in degradation of the key AD proteins. Our findings implicate that enhancing the activity or levels of CtsB/L could provide a promising and a common strategy for maintaining lysosomal function and for preventing and/or treating neurodegenerative diseases.
27902765	8	25	Cathepsin B and L	Gene	1508;1514
27902765	35	44	Lysosomal	Disease	MESH:D016464
27902765	45	56	Dysfunction	Disease	MESH:D006331
27902765	58	61	NPC	Disease	MESH:D052556
27902765	67	78	Cholesterol	Chemical	MESH:D002784
27902765	121	141	Alzheimer's Proteins	Disease	MESH:D000544
27902765	299	309	impairment	Disease	MESH:D060825
27902765	313	322	lysosomal	Disease	MESH:D016464
27902765	359	380	neuronal degeneration	Disease	MESH:D009410
27902765	417	443	neurodegenerative diseases	Disease	MESH:D019636
27902765	544	562	cathepsins B and L	Gene	1508;1514
27902765	564	570	CtsB/L	Gene	9468
27902765	581	590	lysosomal	Disease	MESH:D016464
27902765	601	612	cholesterol	Chemical	MESH:D002784
27902765	651	670	Alzheimer's disease	Disease	MESH:D000544
27902765	672	674	AD	Disease	MESH:D000544
27902765	714	720	CtsB/L	Gene	9468
27902765	756	760	CtsD	Gene	1509
27902765	781	790	lysosomal	Disease	MESH:D016464
27902765	816	825	lysosomal	Disease	MESH:D016464
27902765	850	861	cholesterol	Chemical	MESH:D002784
27902765	878	880	AD	Disease	MESH:D000544
27902765	945	956	cholesterol	Chemical	MESH:D002784
27902765	990	996	CtsB/L	Gene	9468
27902765	1058	1084	neurodegenerative disorder	Disease	MESH:D019636
27902765	1085	1104	Niemann-Pick type C	Disease	MESH:D052556
27902765	1106	1109	NPC	Disease	MESH:D052556
27902765	1112	1118	CtsB/L	Gene	9468
27902765	1156	1160	CtsD	Gene	1509
27902765	1168	1177	lysosomal	Disease	MESH:D016464
27902765	1178	1188	impairment	Disease	MESH:D060825
27902765	1226	1238	EGF receptor	Gene	1956
27902765	1298	1307	lysosomal	Disease	MESH:D016464
27902765	1324	1328	NPC1	Gene	4864
27902765	1333	1337	NPC2	Gene	10577
27902765	1366	1370	NPC1	Gene	4864
27902765	1375	1380	ABCA1	Gene	19
27902765	1396	1407	cholesterol	Chemical	MESH:D002784
27902765	1440	1446	CtsB/L	Gene	9468
27902765	1506	1510	NPC1	Gene	4864
27902765	1546	1551	ABCA1	Gene	19
27902765	1617	1623	CtsB/L	Gene	9468
27902765	1663	1683	Alzheimer's proteins	Disease	MESH:D000544
27902765	1708	1713	Abeta	Gene	351
27902765	1747	1772	amyloid precursor protein	Gene	351
27902765	1817	1822	BACE1	Gene	23621
27902765	1843	1849	CtsB/L	Gene	9468
27902765	1873	1882	lysosomal	Disease	MESH:D016464
27902765	1913	1919	CtsB/L	Gene	9468
27902765	1964	1975	cholesterol	Chemical	MESH:D002784
27902765	2018	2020	AD	Disease	MESH:D000544
27902765	2095	2101	CtsB/L	Gene	9468
27902765	2166	2175	lysosomal	Disease	MESH:D016464
27902765	2220	2246	neurodegenerative diseases	Disease	MESH:D019636
27902765	Association	MESH:D016464	10577
27902765	Association	MESH:D016464	9468
27902765	Negative_Correlation	10577	9468
27902765	Association	MESH:D006331	1508
27902765	Negative_Correlation	4864	9468
27902765	Association	MESH:D052556	1514
27902765	Positive_Correlation	19	9468
27902765	Association	MESH:D002784	4864
27902765	Negative_Correlation	MESH:D000544	9468
27902765	Association	MESH:D016464	1956
27902765	Association	MESH:D016464	1508
27902765	Association	MESH:D016464	1514
27902765	Negative_Correlation	1956	9468
27902765	Association	MESH:D002784	9468
27902765	Association	MESH:D006331	1514
27902765	Association	MESH:D000544	1508
27902765	Association	MESH:D002784	1514
27902765	Association	MESH:D016464	4864
27902765	Negative_Correlation	351	9468
27902765	Association	MESH:D000544	1514
27902765	Association	MESH:D002784	MESH:D052556
27902765	Association	MESH:D002784	MESH:D000544
27902765	Negative_Correlation	MESH:D060825	9468
27902765	Association	MESH:D052556	1508
27902765	Association	MESH:D052556	9468
27902765	Association	MESH:D002784	1508
27902765	Negative_Correlation	23621	9468

